Noticias de Eulerpool Clarity Pharmaceuticals

Clarity Pharmaceuticals Eulerpool-AFX

Clarity Pharmaceuticals Noticias de Acciones

Clarity Pharmaceuticals es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Clarity Pharmaceuticals.

• 1 de junio ·

  Yahoo
  Is Clarity Pharmaceuticals Ltd (ASX:CU6) Trading At A 48% Discount?
• 15 de marzo ·

  Yahoo
  Clarity's theranostic prostate cancer trial advances to multi-dose phase
• 8 de marzo ·

  Yahoo
  Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
• 22 de diciembre ·

  Yahoo
  First patient dosed in Clarity's registrational Phase III prostate cancer trial with Cu-64 SAR-bisPSMA
• 30 de noviembre ·

  Yahoo
  Registrational Phase III CLARIFY trial in prostate cancer commences
• 30 de noviembre ·

  Yahoo
  First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
• 7 de noviembre ·

  Yahoo
  Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
• 26 de octubre ·

  Yahoo
  Clarity and PSI kick off SAR-bisPSMA Phase III
• 3 de octubre ·

  Yahoo
  First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
• 10 de agosto ·

  Yahoo
  Clarity's theranostic prostate cancer trial advances to highest dose level